Candriam S.C.A. increased its holdings in shares of Quest Diagnostics Incorporated (NYSE:DGX - Free Report) by 21.8% in the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 146,410 shares of the medical research company's stock after pu